Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light.
Location: United Kingdom, England, Newcastle upon Tyne
Employees: 11-50
Total raised: $553.1K
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Meneldor | meneldor.n... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.06.2021 | Pre-Seed | $553.1K | - |